Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder

Area of Science:

• Immunology
• Molecular Biology
• Hematology

Background:

• MicroRNAs (miRNAs) are critical regulators of immune system development and function.
• Bacterial lipopolysaccharide (LPS) is a potent immune stimulant.
• Granulocyte/monocyte (GM) progenitors are key myeloid cells involved in immune responses.

Purpose of the Study:

• To investigate the role of microRNA-155 (miR-155) in immune cell expansion following LPS stimulation.
• To determine if miR-155 is sufficient to induce GM expansion and its potential pathological implications.
• To explore the relevance of miR-155 dysregulation in acute myeloid leukemia (AML).

Main Methods:

• Induction of miR-155 in mouse bone marrow using bacterial lipopolysaccharide (LPS).
• Enforced expression of miR-155 in mouse bone marrow cells.
• Analysis of gene expression and cell populations, including comparison with human AML patient samples.

Main Results:

• LPS injection induced a strong, transient increase in miR-155 in mouse bone marrow, correlating with GM expansion.
• Enforced miR-155 expression in bone marrow cells mimicked LPS-induced GM proliferation but led to pathological features resembling myeloid neoplasia.
• miR-155 was overexpressed in bone marrow from certain acute myeloid leukemia (AML) patients and repressed genes involved in hematopoietic development.

Conclusions:

• miR-155 contributes to physiological GM expansion during inflammation.
• miR-155 plays a role in pathological features associated with AML.
• Precise regulation of miR-155 is vital for myeloid cell development, especially under inflammatory stress.